Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients
Outcomes for patients with hematologic malignancy infected with COVID-19 have not been
aggregated. The objective of this study was to perform a systematic review and meta …
aggregated. The objective of this study was to perform a systematic review and meta …
COVID-19 in immunocompromised hosts: what we know so far
M Fung, JM Babik - Clinical Infectious Diseases, 2021 - academic.oup.com
Abstract The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused significant morbidity and …
respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused significant morbidity and …
[HTML][HTML] Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre …
F Passamonti, C Cattaneo, L Arcaini, R Bruna… - The Lancet …, 2020 - thelancet.com
Background Several small studies on patients with COVID-19 and haematological
malignancies are available showing a high mortality in this population. The Italian …
malignancies are available showing a high mortality in this population. The Italian …
[HTML][HTML] Mortality in patients with cancer and coronavirus disease 2019: a systematic review and pooled analysis of 52 studies
Background Patients with coronavirus disease 2019 (COVID-19) who have underlying
malignancy have a higher mortality rate compared with those without cancer, although the …
malignancy have a higher mortality rate compared with those without cancer, although the …
Outcomes of COVID-19 in patients with CLL: a multicenter international experience
AR Mato, LE Roeker, N Lamanna… - Blood, The Journal …, 2020 - ashpublications.org
Given advanced age, comorbidities, and immune dysfunction, chronic lymphocytic leukemia
(CLL) patients may be at particularly high risk of infection and poor outcomes related to …
(CLL) patients may be at particularly high risk of infection and poor outcomes related to …
[HTML][HTML] COVID-19 in immunocompromised patients: a systematic review of cancer, hematopoietic cell and solid organ transplant patients
Background The clinical impact of severe coronavirus disease 2019 (COVID-19), caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in immunocompromised …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in immunocompromised …
[HTML][HTML] COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL …
L Scarfò, T Chatzikonstantinou, GM Rigolin… - Leukemia, 2020 - nature.com
Chronic lymphocytic leukemia (CLL) is a disease of the elderly, characterized by
immunodeficiency. Hence, patients with CLL might be considered more susceptible to …
immunodeficiency. Hence, patients with CLL might be considered more susceptible to …
Clinical characteristics and outcomes of COVID-19–infected cancer patients: a systematic review and meta-analysis
H Zhang, H Han, T He, KE Labbe… - JNCI: Journal of the …, 2021 - academic.oup.com
Background Previous studies have indicated coronavirus disease 2019 (COVID-19) patients
with cancer have a high fatality rate. Methods We conducted a systematic review of studies …
with cancer have a high fatality rate. Methods We conducted a systematic review of studies …
[HTML][HTML] COVID-19 vaccination in pregnancy, paediatrics, immunocompromised patients, and persons with history of allergy or prior SARS-CoV-2 infection: overview …
To date, four vaccines have been authorised for emergency use and under conditional
approval by the European Medicines Agency to prevent COVID-19: Comirnaty, COVID-19 …
approval by the European Medicines Agency to prevent COVID-19: Comirnaty, COVID-19 …
Differences in outcomes and factors associated with mortality among patients with SARS-CoV-2 infection and cancer compared with those without cancer: a …
Importance SARS-CoV-2 infection has been associated with more severe disease and
death in patients with cancer. However, the implications of certain tumor types, treatments …
death in patients with cancer. However, the implications of certain tumor types, treatments …